Close Menu

NEW YORK (GenomeWeb) – Apis Assay Technologies, a company supported by Qiagen and Health Innovation Manchester in the UK, has officially launched with the goal of expediting the commercialization of biomarkers into new diagnostic tests.

According to its website, Apis' business model has three main areas of focus: a biomarker industrial research program; so-called "fast-tracking" of biomarkers and diagnostic platforms for commercialization; and contract development.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.